Pharmaceutical Value proposition
[Automatic translation follows] Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an important member of the Roche Group. Additional information is available at https://www.chugai-pharm.co.jp/english/
Read our Social Media Policy: https://www.chugai-pharm.co.jp/english/rule/sns/index.html
Chugai Pharmaceutical (headquartered in Tokyo) is a research-based pharmaceutical company with strengths in its proprietary drug discovery technology platform, including antibody engineering technology. As an important member of the Roche Group and a listed company on the Prime Market of the Tokyo Stock Exchange, Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs under its autonomous and independent management.
Please refer to our social media policy for usage:
https://www.chugai-pharm.co.jp/rule/sns/index.html
Pharmaceuticals, new drug development, global companies, biopharmaceuticals, pharmaceuticals, biotechnology, healthcare, and innovationOriginal language
Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an important member of the Roche Group. Additional information is available at https://www.chugai-pharm.co.jp/english/
Read our Social Media Policy: https://www.chugai-pharm.co.jp/english/rule/sns/index.html
中外製薬(本社:東京)は、抗体エンジニアリング技術をはじめとする独自の創薬技術基盤を強みとする、研究開発型の製薬企業です。ロシュ・グループの重要なメンバーであるとともに、東京証券取引所プライム市場の上場企業として、自主独立経営の下、アンメットメディカルニーズを満たす革新的な医薬品の創製に取り組んでいます。
ご利用にあたってはソーシャルメディアポリシーをご覧ください:
https://www.chugai-pharm.co.jp/rule/sns/index.html
製薬, 新薬開発, グローバル企業, バイオ医薬品, pharmaceuticals, biotechnology, healthcare, and innovation
中外製薬株式会社｜創造で、想像を超える。
中外製薬株式会社｜創造で、想像を超える。
https://www.chugai-pharm.co.jp/
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Deep Knowledge Analytics Research Services, it services | Other 31 Aug 2024 | | |
 | Klineo healthtech, deeptech | Other 16 Oct 2024 | | |
 | Access Accelerated Civic and Social Organizations, cleantech | Other 15 Jun 2024 | | |
 | Cumulus Neuroscience Biotechnology Research, healthtech, biotech, deeptech | Other 6 Jun 2024 | | |
 | Flying Health entrepreneurship, Business Consulting and Services, healthtech, fintech, deeptech | Other 15 May 2023 | | |